Evidence map›Paper›PMID 15240568›Full record

ArticleThe Journal of cell biology2004

SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.

Philippe Blache, Marc van de Wetering, Isabelle Duluc, Claire Domon, Philippe Berta, Jean-Noël Freund, Hans Clevers, Philippe Jay

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01919567 (Observational Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using SOX-9 Inhibitor.), which is not on this map. Cited by 272 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
272citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01919567 unknown statusnot on this mapstarted 2011, after this paper: background citation

Observational Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using SOX-9 Inhibitor.

TypeobservationalSponsorNational Taiwan University HospitalRan2011 to 2014Enrolled255ConditionsCarcinogenesis, Oral Cancer
3 · Its place in the literature

Who cites it

272 citing papers in PubMed, 1 synthesis or guideline pooled it, 483 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC-High SCLC.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Distinct molecular responses of human intestinal organoids to proton and photon radiation.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Intestinal stem cell niche: An upcoming area of immense importance in gastrointestinal disorders.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025
    Review
  18. Review
  19. A framework for target discovery in rare cancers.bioRxiv : the preprint server for biology · 2024
    Article
  20. Article

212 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Philippe BlacheInstitut de Génétique Humaine, CNRS UPR1142, 141 rue de la Cardonille, 34396 Montpellier, Cedex 5, France.
Marc van de Wetering
Isabelle Duluc
Claire Domon
Philippe Berta
Jean-Noël Freund
Hans Clevers
Philippe Jay
Inserm · FRCancer Genomics Centre · NLInstitut de Génétique Humaine · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TCF and SOX proteins belong to the high mobility group box transcription factor family. Whereas TCFs, the transcriptional effectors of the Wnt pathway, have been widely implicated in the development, homeostasis and disease of the intestine epithelium, little is known about the function of the SOX proteins in this tissue. Here, we identified SOX9 in a SOX expression screening in the mouse fetal intestine. We report that the SOX9 protein is expressed in the intestinal epithelium in a pattern characteristic of Wnt targets. We provide in vitro and in vivo evidence that a bipartite beta-catenin/TCF4 transcription factor, the effector of the Wnt signaling pathway, is required for SOX9 expression in epithelial cells. Finally, in colon epithelium-derived cells, SOX9 transcriptionally represses the CDX2 and MUC2 genes, normally expressed in the mature villus cells of the intestinal epithelium, and may therefore contribute to the Wnt-dependent maintenance of a progenitor cell phenotype.

Indexed as

Animalsbeta CateninBlotting, NorthernBlotting, WesternCarcinomaCDX2 Transcription FactorCell DifferentiationCell Line, TumorCell NucleusColonic NeoplasmsCytoskeletal ProteinsDNAEpitheliumGene Expression Regulation, NeoplasticHigh Mobility Group ProteinsHomeodomain Proteinsbeta CateninCdx2 protein, mouseCDX2 Transcription FactorCTNNB1 protein, humanCTNNB1 protein, mouseCytoskeletal ProteinsDNAHigh Mobility Group ProteinsHomeodomain ProteinsMUC2 protein, humanMuc2 protein, mouseMucin-2MucinsRNASOX9 protein, humanSox9 protein, mouseSOX9 Transcription FactorTrans-ActivatorsTranscription Factors

Identifiers

PMID15240568
PMCPMC2172132
OpenAlexW2139419405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.